1. Home
  2. RYAM vs EOLS Comparison

RYAM vs EOLS Comparison

Compare RYAM & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Advanced Materials Inc.

RYAM

Rayonier Advanced Materials Inc.

HOLD

Current Price

$5.84

Market Cap

422.1M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.85

Market Cap

444.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYAM
EOLS
Founded
1926
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Paper
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
422.1M
444.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RYAM
EOLS
Price
$5.84
$6.85
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$6.00
$20.50
AVG Volume (30 Days)
544.0K
854.3K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,471,356,000.00
$285,823,000.00
Revenue This Year
N/A
$14.24
Revenue Next Year
$6.99
$21.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.10
52 Week Low
$3.35
$5.71
52 Week High
$8.56
$17.12

Technical Indicators

Market Signals
Indicator
RYAM
EOLS
Relative Strength Index (RSI) 41.16 47.29
Support Level $5.59 $7.01
Resistance Level $5.92 $7.25
Average True Range (ATR) 0.22 0.24
MACD -0.02 -0.02
Stochastic Oscillator 27.93 18.49

Price Performance

Historical Comparison
RYAM
EOLS

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: